MAIN ARTICLE
From research bench to veterinary clinic
The initiative grew from studies of how cells defend themselves. Banerjee says researchers placed human cells in contact with pathogenic bacteria and examined the protective molecules released in response. The team isolated candidate peptides and modified them chemically to improve antibacterial activity. Healbac began operating as a private company in November 2025, hoping to take discoveries beyond academic experiments and develop products suited to real-world conditions.
The first application now targets animals. Persistent itching, irritated skin and recurring infections can mean repeated veterinary visits for families. Healbac is working with six Singapore clinics to gather treatment data. The company cites one French bulldog whose symptoms cleared after three days, a useful early observation but not a controlled clinical trial. A single successful case cannot establish how often a medicine works, whether it prevents recurrence or which conditions it can treat.
Why antimicrobial peptides attract attention
Antimicrobial peptides are short chains of amino acids that form part of many organisms' innate defense systems. Some can disrupt bacterial cell membranes; others appear to affect several microbial targets.















